These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Expression of desmoplakin II in tumors].
    Author: Yang J, Luo X, Cai L.
    Journal: Zhonghua Bing Li Xue Za Zhi; 1995 Jun; 24(3):170-2. PubMed ID: 7656386.
    Abstract:
    Desmoplakin II (DPII) is a new marker for identification of epithelium and epithelial tumors. Expression of DPII in 217 tumors cases was studied immunohistochemically by ABC method using an anti-DPII monoclonal antibody which reacts with tissue on formalin-fixed, paraffin-embedded sections. A monoclonal antibody against cytokeratin (CK) was employed to compare with the antibody. Immunohistochemical staining showed that 147 of the 163 epithelial tumors and bi-directional differentiation tumors expressed DPII (90.7%); 92 of the 163 tumors expressed CK (56.4%); 54 tumors lacking desmosome expressed neither DPII nor CK. All CK positive staining was located in cytoplasm while most DPII positive dotty staining was located at the cell-cell borders, some DPII staining was present in cytoplasm. These results demonstrate that the anti-DPII monoclonal antibody is a useful immunohistochemical probe for identification of desmosome-containing tumors. Antibodies against other epithelial markers such as keratin should be employed together with anti-DPII monoclonal antibody when differentiation is made between epithelial and non-epithelial tumors.
    [Abstract] [Full Text] [Related] [New Search]